c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock.
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The proteins encoded by both viral and cellular forms of the c-myc oncogene have been previously demonstrated to have exceptionally short in vivo half-lives. In this paper we report a comparative study on the parameters affecting turnover of nuclear oncoproteins c-myc, c-myb, and the rapidly metabolized cytoplasmic enzyme ornithine decarboxylase. The degradation of all three proteins required metabolic energy, did not result in production of cleavage intermediates, and did not involve lysosomes or ubiquitin. A five- to eightfold increase in the half-life of c-myc proteins, and a twofold increase in the half-life of c-myb proteins was detected after heat-shock treatment at 46 degrees C. In contrast, heat shock had no effect on the turnover of ornithine decarboxylase. Heat shock also had the effect of increasing the rate of c-myc protein synthesis twofold, whereas c-myb protein synthesis was decreased nearly fourfold. The increased stability and synthesis of c-myc proteins led to an overall increase in the total level of c-myc proteins in response to heat-shock treatment. Furthermore, treatments which reduced c-myc and c-myb protein turnover, such as heat shock and exposure to inhibitors of metabolic energy production, resulted in reduced detergent solubility of both proteins. The recovery from heat shock, as measured by increased turnover and solubility, was energy dependent and considerably more rapid in thermotolerant cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roos, A., & Boron, W. F. (1981) · Physiological Reviews · doi:10.1152/physrev.1981.61.2.296 · Cited by 2,511
Hann, S. R., King, M. W., Bentley, D. L., Anderson, C. W., & Eisenman, R. N. (1988) · Cell · doi:10.1016/0092-8674(88)90507-7 · Cited by 474
Self-citation
Cited by
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Self-citationMxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites
Zervos, A. S., Gyuris, J., & Brent, R. (1993) · Cell · doi:10.1016/0092-8674(93)90662-a · Cited by 775
Peptide sequences that target cytosolic proteins for lysosomal proteolysis
Fred Dice, J. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90019-8 · Cited by 754
Histone sumoylation is associated with transcriptional repression
Shiio, Y., & Eisenman, R. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735528100 · Cited by 702
Self-citationOncogenic activity of the c-Myc protein requires dimerization with Max
Amati, B., Brooks, M. W., Levy, N., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · Cell · doi:10.1016/0092-8674(93)90663-b · Cited by 560
Gregory, M. A., & Hann, S. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469
Early auxin-induced genes encode short-lived nuclear proteins.
Abel, S., Oeller, P. W., & Theologis, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.326 · Cited by 446
Myc and Max associate in vivo.
Blackwood, E. M., Lüscher, B., & Eisenman, R. N. (1992) · Genes & Development · doi:10.1101/gad.6.1.71 · Cited by 420
Self-citationMyb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation
Lüscher, B., Christenson, E., Litchfield, D. W., Krebs, E. G., & Eisenman, R. N. (1990) · Nature · doi:10.1038/344517a0 · Cited by 344
Self-citationDegradation of nuclear oncoproteins by the ubiquitin system in vitro.
Ciechanover, A., DiGiuseppe, J. A., Bercovich, B., Orian, A., Richter, J. D., Schwartz, A. L., & Brodeur, G. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.139 · Cited by 339
Differential modulation of cyclin gene expression by MYC.
Jansen-Dürr, P., Meichle, A., Steiner, P., Pagano, M., Finke, K., Botz, J., Wessbecher, J., Draetta, G., & Eilers, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3685 · Cited by 314
Abnormally high expression of proteasomes in human leukemic cells.
Kumatori, A., Tanaka, K., Inamura, N., Sone, S., Ogura, T., Matsumoto, T., Tachikawa, T., Shin, S., & Ichihara, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7071 · Cited by 304
A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
Ayer, D. E., & Eisenman, R. N. (1993) · Genes & Development · doi:10.1101/gad.7.11.2110 · Cited by 291
Self-citationMyc oncoproteins are phosphorylated by casein kinase II.
Lüscher, B., Kuenzel, E. A., Krebs, E. G., & Eisenman, R. N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03481.x · Cited by 279
Self-citationBCR/ABL activates mdm2 mRNA translation via the La antigen
Trotta, R., Vignudelli, T., Candini, O., Intine, R. V., Pecorari, L., Guerzoni, C., Santilli, G., Byrom, M. W., Goldoni, S., Ford, L. P., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00020-5 · Cited by 217
Black, T. L., Safer, B., Hovanessian, A., & Katze, M. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.5.2244-2251.1989 · Cited by 179
Brewer, G., & Ross, J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.5.1996 · Cited by 175
A Two-Step Mechanism for Recruitment of Pip by PU.1
Perkel, J. M., & Atchison, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.241 · Cited by 77
Fisher, R. C., Olson, M. C., Pongubala, J. M. R., Perkel, J. M., Atchison, M. L., Scott, E. W., & Simon, M. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4347 · Cited by 49
Metadata
- Authors
- Lüscher, B., & Eisenman, R. N.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1988-06
- Volume
- 8
- Issue
- 6
- Pages
- 2504-2512
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W1876542488
- Cited by
- 151
- References
- 2
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.